WCMNY
TDACU

Westchester Capital Management (New York)’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Westchester Capital Management (New York)’s Portfolio TDACU Stock Details TDACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-286,180
Closed -$2.87M – 198
2024
Q4 		$2.87M Buy
+286,180
New +$2.87M 0.16% 82

Other funds holding TDACU

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Westchester Capital Management (New York)'s TDACU Position: Q1 2025 in Review

Westchester Capital Management (New York) sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 286,180 shares — an estimated $2.87M sold.

Westchester Capital Management (New York) first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $2.87M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.

  • Westchester Capital Management (New York) reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 286,180 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $2.87M.
  • Westchester Capital Management (New York) first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s Translational Development Acquisition Corp Units position peaked at $2.87M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2025, filed 14 May 2025.